[Effects of diacetoxyscirpenol on experimental candidiasis of mice]

Comptes Rendus Des Seances De L'Academie Des Sciences. Serie D, Sciences Naturelles
|March 31, 1980
PubMed

Insights

A toxin called diacetoxyscirpenol significantly worsened experimental candidiasis in mice infected with Candida albicans. This fungal toxin promoted the growth of C. albicans in mouse kidneys.

Area of Science:

  • Mycology
  • Immunology
  • Toxicology

Background:

  • Fusarium fungi produce mycotoxins, including diacetoxyscirpenol.
  • Candida albicans is an opportunistic fungal pathogen that causes candidiasis.
  • Mycotoxins can impact host immune responses and disease severity.

Purpose of the Study:

  • To investigate the effect of diacetoxyscirpenol on experimental candidiasis in mice.
  • To determine if diacetoxyscirpenol exacerbates Candida albicans infections.

Main Methods:

  • Mice were infected with Candida albicans.
  • A single injection of diacetoxyscirpenol (4.5 mg/kg) was administered.
  • Kidney homogenates were cultured on Sabouraud dextrose agar.
  • Candida albicans colonies were counted after 24 hours.

Main Results:

  • Diacetoxyscirpenol significantly increased the development of experimental candidiasis.
  • Higher counts of Candida albicans were observed in the kidneys of mice treated with the toxin.
  • Statistical analysis showed highly significant differences between groups.

Conclusions:

  • Diacetoxyscirpenol enhances the pathogenicity of Candida albicans in a murine model.
  • This mycotoxin may play a role in the severity of candidiasis.